Skip to content
See your health improve
DigestiveDetected by MRI

Malignant liver tumor (hepatocellular carcinoma)

The most common primary liver cancer, often developing in patients with chronic liver disease or cirrhosis. Early MRI detection widens treatment options and improves survival. MRI can raise suspicion of this finding, but a definitive diagnosis requires further specialist assessment — typically examining a tissue sample (taken by biopsy or during surgical removal), and sometimes additional imaging or blood tests.

Early detection matters

Our comprehensive check-up screens for malignant liver tumor (hepatocellular carcinoma) and hundreds of other conditions.

Book check-upTalk to our team

Related biomarkers we test

Systemic inflammation response index (SIRI)

SIRI combines neutrophils, monocytes, and lymphocytes to evaluate immune response and inflammation severity.

Systemic immune-inflammation index (SII)

SII integrates neutrophil, platelet, and lymphocyte counts into a single measure of immune and inflammatory status.

NLR (neutrophils/lymphocytes)

NLR reflects the balance between neutrophils which drive early inflammation and lymphocytes which regulate immune control.

ASAT / ALAT ratio

This ratio compares two liver enzymes to give insight into liver health.

FIB-4 index

FIB-4 combines age, platelet count, and liver enzymes to estimate the degree of liver fibrosis.

Aspartate aminotransferase (ASAT)

An enzyme present in liver, heart, muscle, and other tissues. While less specific to the liver than ALAT, elevated levels often indicate liver damage when other liver markers are also abnormal.

Alanine aminotransferase (ALAT)

ALAT (Alanine Aminotransferase): An enzyme primarily found in liver cells. When liver cells are damaged, ALAT leaks into the bloodstream, making it a sensitive indicator of liver injury from various causes.

Related conditions in Digestive